XML 20 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
General
12 Months Ended
Dec. 31, 2016
General [Abstract]  
General

1.  General



Pain Therapeutics, Inc. develops proprietary drugs that offer significant improvements to patients and healthcare professionals. We generally focus our drug development efforts on disorders of the nervous system, such as chronic pain.



In the course of our development activities, we have sustained cumulative operating losses. There are no assurances that additional financing will be available on favorable terms, or at all.